Skip to main content
. 2020 Jun 3;182(2):389–399. doi: 10.1007/s10549-020-05711-5

Table 2.

Localization of metastatic lesions

LDMC CCT p
Metastatic sites No. of patients (%)
Bone 25 (62.5%) 56 (70.0%) 0.417
Liver 21 (52.5%) 42 (52.5%) 1.000
Lung 16 (40.0%) 32 (40.0%) 1.000
Pleura 7 (17.5%) 10 (12.5%) 0.579
Peritoneum 2 (5.0%) 9 (11.3%) 0.333
Lymph 12 (30.0%) 23 (28.8%) 1.000
Cerebrum 1 (2.5%) 8 (10.0%) 0.269
Soft tissue (thoracic wall, cutis) 5 (12.5%) 10 (12.5%) 1.000